Connor James Villar

Connor James Villar is an Associate in the Litigation Department and a member of the Intellectual Property and Patent Law Groups at Proskauer Rose LLP. His patent litigation practice encompasses a diverse range of technologies, including software, applications, network security measures, medical devices, and biotechnology. This expertise is evidenced in cases involving blood processing devices, smart dumbbells, LTE patents, and gene-mapping technologies.

Based on available public records, Mr. Villar has represented both plaintiffs and defendants in patent litigation, with a slight tilt toward plaintiff-side appearances in tracked cases. He has been involved in significant matters, including representing Haemonetics Corporation in litigation against Fresenius Kabi USA, LLC. He also contributed to successful outcomes for clients in Federal Circuit appeals, such as the reversal of a § 101 invalidity ruling for PowerBlock Holdings, Inc.'s smart dumbbell patent and the vacating of a $300 million verdict against Apple in an LTE patent dispute. Additionally, he was part of the team involved in the settlement between 10x Genomics and Harvard with Vizgen Inc. regarding gene-mapping technologies.

Mr. Villar is experienced in Patent Trial and Appeal Board (PTAB) proceedings, with "Inter Partes Review (IPR) Proceeding" listed as one of his popular topics. He was counsel for Haemonetics in an IPR context related to the USPTO Director's dismissal rules. His contributions to "The Patent Playbook" blog frequently address developments in Federal Circuit patent law and IPRs, indicating active engagement with PTAB and appellate issues.

Mr. Villar earned his J.D., Magna Cum Laude, from Tulane University Law School and his B.Eng., Cum Laude, from SUNY Maritime College. He is admitted to practice in New York and before the U.S. Patent and Trademark Office.